T-140 peptide analogs having cxcr4 super-agonist activity...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/19 (2006.01) A61K 35/12 (2006.01) A61K 38/10 (2006.01)

Patent

CA 2673719

The present invention is directed to novel therapeutic uses of T- 140 analog peptides and compositions comprising same. Specifically, the invention provides compositions and methods useful for providing improved bone marrow transplantation and in the treatment of other conditions wherein bone marrow depletion or suppression is involved.

L'invention concerne de nouvelles utilisations thérapeutiques de peptides analogues de T-140 et des compositions comprenant de tels peptides. En particulier, l'invention concerne des compositions et des procédés destinés à améliorer une transplantation de moelle osseuse et à traiter d'autres troubles associés à une déplétion ou à une suppression de moelle osseuse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

T-140 peptide analogs having cxcr4 super-agonist activity... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with T-140 peptide analogs having cxcr4 super-agonist activity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T-140 peptide analogs having cxcr4 super-agonist activity... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1609591

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.